We are live on ! Find out more
CCM

Cadence Capital Management Portfolio holdings

AUM $415M
1-Year Est. Return 11.01%
This Fund
S&P 500
This Quarter Est. Return
+5.16%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
AUM
$1.37B
AUM Growth
+$44.5M
Cap. Flow
-$9.6M
Cap. Flow %
-0.7%
Top 10 Hldgs %
10.12%
Holding
687
New
99
Increased
230
Reduced
280
Closed
72

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$12.2M
2
GILD icon
Gilead Sciences
GILD
+$11.6M
3
COP icon
ConocoPhillips
COP
+$5.98M
4
MS icon
Morgan Stanley
MS
+$5.54M
5
CPRI icon
Capri Holdings
CPRI
+$3.95M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$11.9M
2
AIG icon
American International
AIG
+$11.1M
3
TXN icon
Texas Instruments
TXN
+$9.03M
4
PRU icon
Prudential Financial
PRU
+$7.31M
5
GM icon
General Motors
GM
+$6.08M

Sector Composition

Rank Sector Weight
1 Financials 15.46%
2 Industrials 14.03%
3 Technology 11.99%
4 Healthcare 11.73%
5 Consumer Staples 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUFF
676
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
-74,650
Closed -$1.74M
CALD
677
DELISTED
Callidus Software, Inc.
CALD
-46,433
Closed -$928K
GIMO
678
DELISTED
Gigamon Inc.
GIMO
-28,348
Closed -$1.06M
LLTC
679
DELISTED
Linear Technology Corp
LLTC
-30,102
Closed -$1.4M
HAR
680
DELISTED
Harman International Industries
HAR
-10,520
Closed -$756K
STJ
681
DELISTED
St Jude Medical
STJ
-4,734
Closed -$369K
PGND
682
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
-7,200
Closed -$283K
FNFG
683
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
-43,181
Closed -$421K
CPXX
684
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
-20,630
Closed -$623K
VSTO
685
DELISTED
Vista Outdoor Inc.
VSTO
-20,360
Closed -$972K
DNY
686
DELISTED
DONNELLEY R R & SONS CO
DNY
-92,624
Closed -$1.57M
TCF
687
DELISTED
TCF Financial Corporation
TCF
-33,290
Closed -$421K

Similar funds

Cadence Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Cadence Capital Management held 687 positions worth $1.37B, up 3.4% from $1.33B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Cadence Capital Management's Q3 2016 filing shows 99 new, 230 increased, 280 reduced and 72 closed positions. Its largest new stake was Bristol-Myers Squibb: 190,283 shares worth $10.3M. The largest sale was Apple, an estimated $11.9M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.

  • Cadence Capital Management's largest Q3 2016 buy was Bristol-Myers Squibb: 190,283 shares worth $10.3M.
  • Cadence Capital Management added most to Gilead Sciences in Q3 2016, an estimated $11.6M increase.
  • Cadence Capital Management's biggest Q3 2016 reduction was Apple, cutting an estimated $11.9M.
  • Cadence Capital Management fully exited American International in Q3 2016, selling an estimated $11.1M.
  • Cadence Capital Management's ten largest holdings make up 10% of its $1.37B portfolio in Q3 2016.
  • Cadence Capital Management opened 99 new positions and closed 72 in Q3 2016.
  • Cadence Capital Management's portfolio value rose 3.4% quarter-over-quarter to $1.37B.

Based on Cadence Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.